Genedata is collaborating with Astellas to automate the analysis of NGS-based assays in order to ensure the safety of regenerative cell therapy products. The collaboration aims to develop innovative therapies, confirm critical quality attributes, and make informed decisions throughout the drug development process. The Genedata Selector platform, which is compliant with FAIR data principles, consolidates scientific and validation consulting services and offers user-friendly interfaces for automating NGS-based analyses. With this collaboration, researchers can easily access, monitor, and track sample information, promoting data democratization and collaboration.
AIRM, a biopharmaceutical company, plans to utilize Genedata Selector to automate workflows, reduce bottlenecks, and accelerate the progress of cell therapies. The collaboration between Genedata and Astellas is expected to bring therapies to market more efficiently.
Genedata is a software solutions company that transforms data into intelligence for biopharmaceutical research and development processes. Their solutions are used by multinational biopharmaceutical organizations and cutting-edge biotechs worldwide to digitalize and automate data-rich and complex R&D processes. Genedata has offices in Basel, Switzerland, as well as in Boston, London, Munich, San Francisco, Singapore, and Tokyo.
http://www.genedata.com
LinkedIn | Twitter | YouTube
________________________________________
Contact
Allison Kurz
Genedata
Public Relations
+41 61 511 84 00
Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.
SOURCE Genedata
